<?xml version="1.0" encoding="UTF-8"?>
<iati-activities version="2.03">
 <iati-activity default-currency="USD" hierarchy="2" iati-activities:version="2.03" xml:lang="EN" xmlns:gavi="http://gavi.org/" xmlns:iati-activities="http://d-portal.org/xmlns/iati-activities">
  <iati-identifier>47122-HTI-TCA</iati-identifier>
  <reporting-org ref="47122" type="40">
   <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
  </reporting-org>
  <title>
   <narrative xml:lang="EN">Haiti: Targeted country assistance</narrative>
   <narrative xml:lang="FR">Ha&#xEF;ti: Aide cibl&#xE9;e aux pays</narrative>
  </title>
  <description type="1">
   <narrative xml:lang="FR">L&#x2019;assistance technique est un soutien non financier fourni par des sp&#xE9;cialistes. Elle peut rev&#xEA;tir plusieurs formes : partage d&#x2019;information et de savoir-faire, formation et services-conseils.

L&#x2019;assistance technique fournie dans le cadre du PEF est appel&#xE9;e aide cibl&#xE9;e aux pays. Ce type de soutien vise principalement &#xE0; payer le personnel bas&#xE9; en permanence dans les bureaux pays des partenaires. Il repose sur la demande et les besoins identifi&#xE9;s par les pays eux-m&#xEA;mes.</narrative>
   <narrative xml:lang="EN">Technical assistance is non-financial support provided by specialists. It can take the form of sharing information and expertise, training and consulting services.

The technical assistance provided through PEF is called targeted country assistance (TCA). This type of support mainly consists of staff permanently based in partners&#x2019; country offices. It is based on the demand and needs identified by the countries themselves.</narrative>
  </description>
  <description type="4">
   <narrative xml:lang="FR">Cette activit&#xE9; d&#xE9;taille notre travail sur le Aide cibl&#xE9;e aux pays en Ha&#xEF;ti, gr&#xE2;ce &#xE0; la mise &#xE0; disposition des donn&#xE9;es budg&#xE9;taires et des transactions. Nous fournissons &#xE9;galement les documents pertinents qui guident ces activit&#xE9;s que sont les formulaires de demande de soutien fournis par le gouvernement de Ha&#xEF;ti ainsi que les lettres de d&#xE9;cisions &#xE9;mises par Gavi, pour progresser. Ces documents d&#xE9;crivent les activit&#xE9;s, les objectifs ainsi que les b&#xE9;n&#xE9;ficiaires.</narrative>
   <narrative xml:lang="EN">This activity details our work on Targeted country assistance in Haiti through the provision of budget and transaction data.  We also provide the relevant documents that guide these activities, which are the support request proposal(s) provided by the Government of Haiti, as well as the decision letter(s) issued by Gavi, for progress.  These documents describe the activities, the objectives as well as the beneficiaries.</narrative>
  </description>
  <participating-org role="4">
   <narrative xml:lang="EN">CDC Foundation</narrative>
  </participating-org>
  <participating-org role="4" type="70">
   <narrative xml:lang="EN">Dalberg Consulting CC</narrative>
  </participating-org>
  <participating-org ref="47122" role="1" type="40">
   <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
  </participating-org>
  <participating-org ref="47122" role="3" type="40">
   <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
  </participating-org>
  <participating-org ref="XM-DAC-44001" role="4" type="40">
   <narrative xml:lang="EN">International Bank for Reconstruction and Development (IBRD)</narrative>
  </participating-org>
  <participating-org role="4" type="70">
   <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
  </participating-org>
  <participating-org role="4" type="10">
   <narrative xml:lang="EN">The Government of Haiti</narrative>
  </participating-org>
  <participating-org ref="XM-DAC-41122" role="4" type="40">
   <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
  </participating-org>
  <participating-org ref="XI-GRID-grid.5510.1" role="4" type="80">
   <narrative xml:lang="EN">University of Oslo</narrative>
  </participating-org>
  <participating-org ref="XM-DAC-928" role="4" type="40">
   <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
  </participating-org>
  <other-identifier ref="47122" type="B1">
   <owner-org ref="47122">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </owner-org>
  </other-identifier>
  <activity-status code="2"></activity-status>
  <activity-date iso-date="2019-01-01" type="1"></activity-date>
  <activity-date iso-date="2019-01-01" type="2"></activity-date>
  <activity-date iso-date="2022-12-31" type="3"></activity-date>
  <contact-info type="1">
   <organisation>
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </organisation>
   <email>info@gavi.org</email>
   <website>http://www.gavi.org/</website>
  </contact-info>
  <activity-scope code="4"></activity-scope>
  <recipient-country code="HT" percentage="100"></recipient-country>
  <location>
   <location-reach code="1"></location-reach>
   <location-id code="HT" vocabulary="A4"></location-id>
   <name>
    <narrative xml:lang="EN">Port-au-Prince</narrative>
   </name>
   <administrative code="HT" vocabulary="A4"></administrative>
   <point srsName="http://www.opengis.net/def/crs/EPSG/0/4326">
    <pos>18.53917 -72.335</pos>
   </point>
   <exactness code="2"></exactness>
   <location-class code="2"></location-class>
  </location>
  <sector code="TCA" percentage="100" vocabulary="99">
   <narrative xml:lang="EN">Targeted country assistance</narrative>
  </sector>
  <sector code="12250" percentage="100" vocabulary="1"></sector>
  <tag code="1" vocabulary="2"></tag>
  <tag code="10" vocabulary="2"></tag>
  <tag code="11" vocabulary="2"></tag>
  <tag code="13" vocabulary="2"></tag>
  <tag code="16" vocabulary="2"></tag>
  <tag code="17" vocabulary="2"></tag>
  <tag code="2" vocabulary="2"></tag>
  <tag code="3" vocabulary="2"></tag>
  <tag code="4" vocabulary="2"></tag>
  <tag code="5" vocabulary="2"></tag>
  <tag code="7" vocabulary="2"></tag>
  <tag code="8" vocabulary="2"></tag>
  <tag code="9" vocabulary="2"></tag>
  <policy-marker code="1" significance="2" vocabulary="1"></policy-marker>
  <policy-marker code="9" significance="2" vocabulary="1"></policy-marker>
  <collaboration-type code="2"></collaboration-type>
  <default-flow-type code="10"></default-flow-type>
  <default-finance-type code="110"></default-finance-type>
  <default-aid-type code="C01" vocabulary="1"></default-aid-type>
  <default-tied-status code="5"></default-tied-status>
  <budget status="2" type="2">
   <period-start iso-date="2019-01-01"></period-start>
   <period-end iso-date="2019-12-31"></period-end>
   <value currency="USD" value-date="2022-03-29">2202806</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2020-01-01"></period-start>
   <period-end iso-date="2020-12-31"></period-end>
   <value currency="USD" value-date="2022-03-29">3031933</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2021-01-01"></period-start>
   <period-end iso-date="2021-12-31"></period-end>
   <value currency="USD" value-date="2022-03-29">2493714</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2022-01-01"></period-start>
   <period-end iso-date="2022-12-31"></period-end>
   <value currency="USD" value-date="2022-03-29">540282</value>
  </budget>
  <capital-spend percentage="0"></capital-spend>
  <transaction ref="HTIPEF-TCA-BOTOKO2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">153000</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-BOTOKO</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="HTIPEF-TCA-CDC FOUND2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">216160</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-CDC FOUND (CDC Foundation)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">CDC Foundation</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="HTIPEF-TCA-DALBERG2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">215097</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-DALBERG (Dalberg Consulting CC)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Dalberg Consulting CC</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="HTIPEF-TCA-IBRD2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">200000</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-IBRD (International Bank for Reconstruction and Development (IBRD))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">International Bank for Reconstruction and Development (IBRD)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="HTIPEF-TCA-JSI2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">371210</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="HTIPEF-TCA-UNI OF OSLO2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">8594</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="HTIPEF-TCA-UNIC2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">371547</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="HTIPEF-TCA-WHO2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">667197</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="HTIPEF-TCA-BOTOKO2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">154800</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-BOTOKO</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="HTIPEF-TCA-CDC FOUND2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">151200</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-CDC FOUND (CDC Foundation)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">CDC Foundation</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="HTIPEF-TCA-DALBERG2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">216247</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-DALBERG (Dalberg Consulting CC)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Dalberg Consulting CC</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="HTIPEF-TCA-IBRD2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">200000</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-IBRD (International Bank for Reconstruction and Development (IBRD))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">International Bank for Reconstruction and Development (IBRD)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="HTIPEF-TCA-JSI2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">532902</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="HTIPEF-TCA-UNI OF OSLO2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">13854</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="HTIPEF-TCA-UNIC2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">719030</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="HTIPEF-TCA-WHO2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">1043901</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="HTIPEF-TCA-BOTOKO2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">156600</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-BOTOKO</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="HTIPEF-TCA-CDC FOUND2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">288120</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-CDC FOUND (CDC Foundation)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">CDC Foundation</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="HTIPEF-TCA-DALBERG2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">-13464</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-DALBERG (Dalberg Consulting CC)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Dalberg Consulting CC</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="HTIPEF-TCA-IBRD2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">100000</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-IBRD (International Bank for Reconstruction and Development (IBRD))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">International Bank for Reconstruction and Development (IBRD)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="HTIPEF-TCA-JSI2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">173209</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="HTIPEF-TCA-UNI OF OSLO2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">36701</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="HTIPEF-TCA-UNIC2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">570732</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="HTIPEF-TCA-WHO2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">1181815</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="HTIPEF-TCA-BOTOKO2022">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2022-01-01"></transaction-date>
   <value currency="USD" value-date="2022-01-01">0</value>
   <description>
    <narrative xml:lang="EN">2022 Operational budget for PEF-TCA-BOTOKO</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="HTIPEF-TCA-CDC FOUND2022">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2022-01-01"></transaction-date>
   <value currency="USD" value-date="2022-01-01">79240</value>
   <description>
    <narrative xml:lang="EN">2022 Operational budget for PEF-TCA-CDC FOUND (CDC Foundation)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">CDC Foundation</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="HTIPEF-TCA-JSI2022">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2022-01-01"></transaction-date>
   <value currency="USD" value-date="2022-01-01">0</value>
   <description>
    <narrative xml:lang="EN">2022 Operational budget for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="HTIPEF-TCA-UNIC2022">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2022-01-01"></transaction-date>
   <value currency="USD" value-date="2022-01-01">141914</value>
   <description>
    <narrative xml:lang="EN">2022 Operational budget for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="HTIPEF-TCA-WHO2022">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2022-01-01"></transaction-date>
   <value currency="USD" value-date="2022-01-01">319128</value>
   <description>
    <narrative xml:lang="EN">2022 Operational budget for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900002699">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-03-31"></transaction-date>
   <value currency="USD" value-date="2019-03-31">41000</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-BOTOKO</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="9900002723">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-06-30"></transaction-date>
   <value currency="USD" value-date="2019-06-30">65750</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-BOTOKO</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="9900002746">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-07-31"></transaction-date>
   <value currency="USD" value-date="2019-07-31">-34750</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-BOTOKO</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="9900007320">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-09-20"></transaction-date>
   <value currency="USD" value-date="2019-09-20">27000</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-BOTOKO</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100000256">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-10-31"></transaction-date>
   <value currency="USD" value-date="2019-10-31">12600</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-BOTOKO</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100000535">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-11-25"></transaction-date>
   <value currency="USD" value-date="2019-11-25">13800</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-BOTOKO</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100000834">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-12-10"></transaction-date>
   <value currency="USD" value-date="2019-12-10">12600</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-BOTOKO</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100001328">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-12-31"></transaction-date>
   <value currency="USD" value-date="2019-12-31">10200</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-BOTOKO</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100000538">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-02-26"></transaction-date>
   <value currency="USD" value-date="2020-02-26">8400</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-BOTOKO</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100001063">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-03-24"></transaction-date>
   <value currency="USD" value-date="2020-03-24">12000</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-BOTOKO</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100001699">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-04-29"></transaction-date>
   <value currency="USD" value-date="2020-04-29">13200</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-BOTOKO</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100002454">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-06-18"></transaction-date>
   <value currency="USD" value-date="2020-06-18">12600</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-BOTOKO</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100002453">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-06-18"></transaction-date>
   <value currency="USD" value-date="2020-06-18">13200</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-BOTOKO</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100004133">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-10-13"></transaction-date>
   <value currency="USD" value-date="2020-10-13">12600</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-BOTOKO</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100003521">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-10-13"></transaction-date>
   <value currency="USD" value-date="2020-10-13">13200</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-BOTOKO</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100004132">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-10-13"></transaction-date>
   <value currency="USD" value-date="2020-10-13">13800</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-BOTOKO</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100005212">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-15"></transaction-date>
   <value currency="USD" value-date="2020-12-15">12600</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-BOTOKO</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100005210">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-15"></transaction-date>
   <value currency="USD" value-date="2020-12-15">13200</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-BOTOKO</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100005211">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-15"></transaction-date>
   <value currency="USD" value-date="2020-12-15">13200</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-BOTOKO</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="9900000005">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">-4800</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-BOTOKO</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="9900000008">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">4800</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-BOTOKO</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100001504">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-04-22"></transaction-date>
   <value currency="USD" value-date="2021-04-22">12000</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-BOTOKO</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100001503">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-04-26"></transaction-date>
   <value currency="USD" value-date="2021-04-26">6000</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-BOTOKO</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100001502">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-06-09"></transaction-date>
   <value currency="USD" value-date="2021-06-09">12000</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-BOTOKO</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100004698">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-09-28"></transaction-date>
   <value currency="USD" value-date="2021-09-28">13800</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-BOTOKO</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100005879">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-11-08"></transaction-date>
   <value currency="USD" value-date="2021-11-08">13200</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-BOTOKO</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100005880">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-11-08"></transaction-date>
   <value currency="USD" value-date="2021-11-08">13200</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-BOTOKO</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100006238">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-11-17"></transaction-date>
   <value currency="USD" value-date="2021-11-17">12600</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-BOTOKO</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100006237">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-11-17"></transaction-date>
   <value currency="USD" value-date="2021-11-17">13200</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-BOTOKO</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100006239">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-11-17"></transaction-date>
   <value currency="USD" value-date="2021-11-17">13200</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-BOTOKO</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100006258">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-11-18"></transaction-date>
   <value currency="USD" value-date="2021-11-18">13200</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-BOTOKO</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100006257">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-11-22"></transaction-date>
   <value currency="USD" value-date="2021-11-22">12600</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-BOTOKO</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100006256">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-11-22"></transaction-date>
   <value currency="USD" value-date="2021-11-22">13200</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-BOTOKO</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="9900000944">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-03-31"></transaction-date>
   <value currency="USD" value-date="2019-03-31">162120</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CDC FOUND (CDC Foundation)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">CDC Foundation</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000675">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-12-02"></transaction-date>
   <value currency="USD" value-date="2019-12-02">54040</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CDC FOUND (CDC Foundation)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">CDC Foundation</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001735">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-04-29"></transaction-date>
   <value currency="USD" value-date="2020-04-29">151200</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CDC FOUND (CDC Foundation)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">CDC Foundation</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001204">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-03-23"></transaction-date>
   <value currency="USD" value-date="2021-03-23">50400</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CDC FOUND (CDC Foundation)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">CDC Foundation</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100002631">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-06-08"></transaction-date>
   <value currency="USD" value-date="2021-06-08">237720</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CDC FOUND (CDC Foundation)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">CDC Foundation</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900001040">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-03-31"></transaction-date>
   <value currency="USD" value-date="2019-03-31">18488</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-DALBERG (Dalberg Consulting CC)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Dalberg Consulting CC</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900001207">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-06-30"></transaction-date>
   <value currency="USD" value-date="2019-06-30">62681</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-DALBERG (Dalberg Consulting CC)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Dalberg Consulting CC</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900001337">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-07-31"></transaction-date>
   <value currency="USD" value-date="2019-07-31">28014</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-DALBERG (Dalberg Consulting CC)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Dalberg Consulting CC</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001160">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-12-31"></transaction-date>
   <value currency="USD" value-date="2019-12-31">24555</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-DALBERG (Dalberg Consulting CC)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Dalberg Consulting CC</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001159">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-12-31"></transaction-date>
   <value currency="USD" value-date="2019-12-31">81360</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-DALBERG (Dalberg Consulting CC)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Dalberg Consulting CC</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001504">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-04-21"></transaction-date>
   <value currency="USD" value-date="2020-04-21">19099</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-DALBERG (Dalberg Consulting CC)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Dalberg Consulting CC</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100002483">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-06-22"></transaction-date>
   <value currency="USD" value-date="2020-06-22">81360</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-DALBERG (Dalberg Consulting CC)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Dalberg Consulting CC</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100002867">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-07-13"></transaction-date>
   <value currency="USD" value-date="2020-07-13">7500</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-DALBERG (Dalberg Consulting CC)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Dalberg Consulting CC</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100005048">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-07"></transaction-date>
   <value currency="USD" value-date="2020-12-07">81360</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-DALBERG (Dalberg Consulting CC)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Dalberg Consulting CC</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100005359">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-14"></transaction-date>
   <value currency="USD" value-date="2020-12-14">13463</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-DALBERG (Dalberg Consulting CC)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Dalberg Consulting CC</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700005576">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">13464</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-DALBERG (Dalberg Consulting CC)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Dalberg Consulting CC</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700000176">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">-13464</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-DALBERG (Dalberg Consulting CC)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Dalberg Consulting CC</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900001132">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-06-30"></transaction-date>
   <value currency="USD" value-date="2019-06-30">200000</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-IBRD (International Bank for Reconstruction and Development (IBRD))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-44001" type="40">
    <narrative xml:lang="EN">International Bank for Reconstruction and Development (IBRD)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001342">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-04-06"></transaction-date>
   <value currency="USD" value-date="2020-04-06">200000</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-IBRD (International Bank for Reconstruction and Development (IBRD))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-44001" type="40">
    <narrative xml:lang="EN">International Bank for Reconstruction and Development (IBRD)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100002781">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-06-17"></transaction-date>
   <value currency="USD" value-date="2021-06-17">100000</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-IBRD (International Bank for Reconstruction and Development (IBRD))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-44001" type="40">
    <narrative xml:lang="EN">International Bank for Reconstruction and Development (IBRD)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900001039">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-03-31"></transaction-date>
   <value currency="USD" value-date="2019-03-31">34774</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900001206">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-06-30"></transaction-date>
   <value currency="USD" value-date="2019-06-30">137471</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900001336">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-07-31"></transaction-date>
   <value currency="USD" value-date="2019-07-31">63113</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001162">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-12-31"></transaction-date>
   <value currency="USD" value-date="2019-12-31">135853</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100002971">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-08-13"></transaction-date>
   <value currency="USD" value-date="2020-08-13">195792</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000005">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">-223680</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700005575">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">163900</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000007">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">223680</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700000170">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">-163900</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000694">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-02-18"></transaction-date>
   <value currency="USD" value-date="2021-02-18">163900</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700000318">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-11-19"></transaction-date>
   <value currency="USD" value-date="2019-11-19">7604</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700001283">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-12-31"></transaction-date>
   <value currency="USD" value-date="2019-12-31">-513</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100004005">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-09-30"></transaction-date>
   <value currency="USD" value-date="2020-09-30">804</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100004212">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-11-10"></transaction-date>
   <value currency="USD" value-date="2020-11-10">2374</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000005">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">-10601</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000007">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">10601</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100004265">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-09-07"></transaction-date>
   <value currency="USD" value-date="2021-09-07">700</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100004623">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-09-23"></transaction-date>
   <value currency="USD" value-date="2021-09-23">75</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700006603">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-12-31"></transaction-date>
   <value currency="USD" value-date="2021-12-31">338</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000945">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-03-31"></transaction-date>
   <value currency="USD" value-date="2019-03-31">337770</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-41122" type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000229">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-02-04"></transaction-date>
   <value currency="USD" value-date="2020-02-04">33777</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-41122" type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000867">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-03-17"></transaction-date>
   <value currency="USD" value-date="2020-03-17">39407</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-41122" type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001481">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-04-14"></transaction-date>
   <value currency="USD" value-date="2020-04-14">337770</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-41122" type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700005028">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-01"></transaction-date>
   <value currency="USD" value-date="2020-12-01">-33777</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-41122" type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700005028">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-01"></transaction-date>
   <value currency="USD" value-date="2020-12-01">33777</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-41122" type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100005692">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-21"></transaction-date>
   <value currency="USD" value-date="2020-12-21">308076</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-41122" type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001377">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-03-30"></transaction-date>
   <value currency="USD" value-date="2021-03-30">112590</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-41122" type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100002314">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-05-25"></transaction-date>
   <value currency="USD" value-date="2021-05-25">32400</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-41122" type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100002681">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-06-10"></transaction-date>
   <value currency="USD" value-date="2021-06-10">425742</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-41122" type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000946">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-03-31"></transaction-date>
   <value currency="USD" value-date="2019-03-31">588704</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-928" type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000231">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-02-04"></transaction-date>
   <value currency="USD" value-date="2020-02-04">78494</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-928" type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001657">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-04-28"></transaction-date>
   <value currency="USD" value-date="2020-04-28">589838</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-928" type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700005028">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-01"></transaction-date>
   <value currency="USD" value-date="2020-12-01">-78494</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-928" type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700005028">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-01"></transaction-date>
   <value currency="USD" value-date="2020-12-01">78494</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-928" type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100005691">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-21"></transaction-date>
   <value currency="USD" value-date="2020-12-21">375570</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-928" type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001826">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-04-27"></transaction-date>
   <value currency="USD" value-date="2021-04-27">196613</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-928" type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100002722">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-06-10"></transaction-date>
   <value currency="USD" value-date="2021-06-10">957383</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-928" type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100002910">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-06-29"></transaction-date>
   <value currency="USD" value-date="2021-06-29">27820</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-928" type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/news/document-library/role-expanded-partners-under-pef-guidance-note">
   <title>
    <narrative xml:lang="EN">Partners&#x2019; engagement framework</narrative>
   </title>
   <description>
    <narrative xml:lang="EN">Guidance on the role of expanded partners in the provision of targeted country assistance</narrative>
   </description>
   <category code="A04"></category>
   <language code="EN"></language>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/fr/actualites/librarie-de-documents/directives-concernant-le-processus-mis-en-place-au-titre-de-laide">
   <title>
    <narrative xml:lang="EN">Directives concernant le processus mis en place au titre de l&#x2019;aide cibl&#xE9;e aux pays dans le cadre du PEF</narrative>
   </title>
   <category code="A04"></category>
   <language code="FR"></language>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/fr/actualites/librarie-de-documents/targeted-country-assistance-plan-haiti-2017-french">
   <title>
    <narrative xml:lang="EN">Targeted country assistance plan Haiti 2017 [French]</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="FR"></language>
   <document-date iso-date="2017-12-31"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/news/document-library/targeted-country-assistance-plan-haiti-2017-french">
   <title>
    <narrative xml:lang="EN">Targeted country assistance plan Haiti 2017 [French]</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="FR"></language>
   <document-date iso-date="2017-12-31"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/fr/actualites/librarie-de-documents/targeted-country-assistance-plan-haiti-2018-french">
   <title>
    <narrative xml:lang="EN">Targeted country assistance plan Haiti 2018 [French]</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="FR"></language>
   <document-date iso-date="2018-12-31"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/news/document-library/targeted-country-assistance-plan-haiti-2018-french">
   <title>
    <narrative xml:lang="EN">Targeted country assistance plan Haiti 2018 [French]</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="FR"></language>
   <document-date iso-date="2018-12-31"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/fr/actualites/librarie-de-documents/targeted-country-assistance-plan-haiti-2019">
   <title>
    <narrative xml:lang="EN">Targeted Country Assistance Plan Haiti 2019</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2019-12-31"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/news/document-library/targeted-country-assistance-plan-haiti-2019">
   <title>
    <narrative xml:lang="EN">Targeted Country Assistance Plan Haiti 2019</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2019-12-31"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/news/document-library/targeted-country-assistance-plan-haiti-2020">
   <title>
    <narrative xml:lang="EN">Targeted Country Assistance Plan Haiti 2020</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2020-07-13"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/news/document-library/targeted-country-assistance-plan-haiti-2021">
   <title>
    <narrative xml:lang="EN">Targeted Country Assistance Plan Haiti 2021</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2021-05-31"></document-date>
  </document-link>
  <document-link format="TEXT/HTML" url="https://www.gavi.org/types-support/pef/targeted-country-assistance">
   <title>
    <narrative xml:lang="EN">About targeted country assistance</narrative>
   </title>
   <category code="A12"></category>
   <language code="EN"></language>
  </document-link>
  <document-link format="TEXT/HTML" url="https://www.gavi.org/fr/types-de-soutien/pef/aide-ciblee-aux-pays">
   <title>
    <narrative xml:lang="EN">&#xC0; propos de l&#x2019;aide cibl&#xE9;e aux pays</narrative>
   </title>
   <category code="A12"></category>
   <language code="FR"></language>
  </document-link>
  <related-activity ref="47122-HTI" type="1"></related-activity>
  <conditions attached="1">
   <condition type="2">
    <narrative xml:lang="EN">Conditions are detailed in the Partners&#x2019; engagement framework</narrative>
    <narrative xml:lang="FR">Conditions are detailed in the Partners&#x2019; engagement framework</narrative>
   </condition>
  </conditions>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Programme Implementation/Coverage &amp; Equity</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1) Evaluation conjointe 2e ann&#xE9;e RSS2 
2) Pr&#xE9;paration plan de mise en ?uvre 3e ann&#xE9;e 
3) 100%&#xA0; ex&#xE9;cution du&#xA0;2e d&#xE9;caissement RSS GAVI fin juin 2021
4) Pr&#xE9;paration de l&apos;&#xE9;valuation conjointe 2020</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1) Appui technique &#xE0; la coordination du projet RSS 2
2) Appui technique &#xE0; l&apos;ex&#xE9;cution technique et financi&#xE8;re&#xA0;du projet RSS 2
3) Suivi du plan de travail RSS2&#xA0;2e ann&#xE9;e
4) Appui technique aux DDS dans la mise en ?uvre des activit&#xE9;s RSS2 : monitoring, microplanification, formation SYS, recyclage normes et proc&#xE9;dures, et supervision
5) Accompagnement aux activit&#xE9;s de&#xA0; renforcement de l&apos;extension du nouveau mod&#xE8;le de soins de sant&#xE9; et renforcement de la gestion locale de&#xA0;sant&#xE9;&#xA0; (D&#xE9;partements de l&apos;Ouest et du Sud)
6) Planification de la mise en ?uvre des 3e et 4e ann&#xE9;es du projet RSS 2">
      <location ref="HT"></location>
     </target>
     <actual value="Completed">
      <location ref="HT"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1) Appui technique &#xE0; la coordination du projet RSS 2
2) Appui technique &#xE0; l&apos;ex&#xE9;cution technique et financi&#xE8;re&#xA0;du projet RSS 2
3) Suivi du plan de travail RSS2&#xA0;2e ann&#xE9;e
4) Appui technique aux DDS dans la mise en ?uvre des activit&#xE9;s RSS2 : monitoring, microplanification, formation SYS, recyclage normes et proc&#xE9;dures, et supervision
5) Accompagnement aux activit&#xE9;s de&#xA0; renforcement de l&apos;extension du nouveau mod&#xE8;le de soins de sant&#xE9; et renforcement de la gestion locale de&#xA0;sant&#xE9;&#xA0; (D&#xE9;partements de l&apos;Ouest et du Sud)
6) Planification de la mise en ?uvre des 3e et 4e ann&#xE9;es du projet RSS 2">
      <location ref="HT"></location>
     </target>
     <actual value="Completed">
      <location ref="HT"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1) le rapport de supervision formative des cadres des 10 departements est disponible&#xA0; 
2)&#xA0;le rapport de formation de 100% des cadres de departement du MSPP sur la surveillance des MEV est disponible 3)Tous les cas inad&#xE9;quats de PFA et de RR de l&apos;ann&#xE9;e 2020 sont classifi&#xE9;s par le comit&#xE9; national des experts</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1)&#xA0; Appui &#xE0; la formation des cadres des departements, des prestataires (auxiliaires, infirmi&#xE8;res, agents, etc?) et la supervision formative des cadres du MSPP 
2) Appui &#xE0; la surveillance et r&#xE9;ponse aux &#xE9;v&#xE8;nements ou &#xE9;pid&#xE9;mie de MEV&#xA0; 3) appui au sous comite surveillance 4) appui a la coordination du circuit de l&apos;information entre la DELR, le LNSP, l&apos;UCNPV et l&apos;OPS">
      <location ref="HT"></location>
     </target>
     <actual value="On Track">
      <location ref="HT"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1)&#xA0; Appui &#xE0; la formation des cadres des departements, des prestataires (auxiliaires, infirmi&#xE8;res, agents, etc?) et la supervision formative des cadres du MSPP 
2) Appui &#xE0; la surveillance et r&#xE9;ponse aux &#xE9;v&#xE8;nements ou &#xE9;pid&#xE9;mie de MEV&#xA0; 3) appui au sous comite surveillance 4) appui a la coordination du circuit de l&apos;information entre la DELR, le LNSP, l&apos;UCNPV et l&apos;OPS">
      <location ref="HT"></location>
     </target>
     <actual value="On Track">
      <location ref="HT"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">John Snow, Inc.</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Phone registration systems in place and SMS reminders to clients for remaining visits and vaccinations</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Set up an SMS reminder system based on the follow-up of client data">
      <location ref="HT"></location>
     </target>
     <actual value="Completed">
      <location ref="HT"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">CDC Foundation : Data</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">National diphtheria surveillance continues with laboratory confirmation (culture and Elek) at LNSP; surveillance data shared quarterly with partners (March, June, Sept, Dec). Sentinel site (4 sites) pertussis surveillance continues with laboratory confirmation (PCR) at LNSP; surveillance data shared quarterly with partners (March, June, Sept, Dec). Support for laboratory capacity offered upon request including supplies and technical expertise. The consultant will submit regular epidemiology reports to key stakeholders on a monthly basis; these reports will focus on pertussis and diphtheria epidemiology, to include case counts by age group, sex, department, vaccination status, and laboratory confirmation status. The consultant will also provide feedback to departments on data missing from case reports.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="COVID-19 response activities have impacted ongoing vaccine-preventable disease work around the world, including Haiti. The coming year offers the opportunity to reset the agenda for current work in diphtheria and pertussis surveillance in Haiti. The objectives of this project will continue to be supporting the strengthening of diphtheria and pertussis surveillance, by reinforcing laboratory and data management capacities. Specifically, the project will support pertussis and diphtheria laboratory trainings and supplies; continued development of pertussis surveillance at sentinel sites and necessary staffing; assessment and dissemination of diphtheria epidemiology over the last 6 years; support of a consultant to strengthen routine analysis of surveillance data including risk assessement and preparation of regular epidemiology reports that will be shared with key stakeholders including Haiti Ministry of Health, CDC, PAHO; and, integration of pertussis and diphtheria surveillance data into an online surveillance platform which will allow linkage of epidemiology and laboratory data.">
      <location ref="HT"></location>
     </target>
     <actual value="Major Delays">
      <location ref="HT"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="COVID-19 response activities have impacted ongoing vaccine-preventable disease work around the world, including Haiti. The coming year offers the opportunity to reset the agenda for current work in diphtheria and pertussis surveillance in Haiti. The objectives of this project will continue to be supporting the strengthening of diphtheria and pertussis surveillance, by reinforcing laboratory and data management capacities. Specifically, the project will support pertussis and diphtheria laboratory trainings and supplies; continued development of pertussis surveillance at sentinel sites and necessary staffing; assessment and dissemination of diphtheria epidemiology over the last 6 years; support of a consultant to strengthen routine analysis of surveillance data including risk assessement and preparation of regular epidemiology reports that will be shared with key stakeholders including Haiti Ministry of Health, CDC, PAHO; and, integration of pertussis and diphtheria surveillance data into an online surveillance platform which will allow linkage of epidemiology and laboratory data.">
      <location ref="HT"></location>
     </target>
     <actual value="Major Delays">
      <location ref="HT"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">National diphtheria surveillance continues with laboratory confirmation (culture and Elek) at LNSP; surveillance data shared quarterly with partners (March, June, Sept, Dec). Sentinel site (4 sites) pertussis surveillance continues with laboratory confirmation at LNSP (PCR); surveillance data shared quarterly with partners (March, June, Sept, Dec). Support for laboratory capacity offered upon request including supplies and technical expertise. Pilot expansion of laboratory expertise for pertussis and diphtheria PCR testing at a regional laboratory site. Pilot integration of either pertussis or diphtheria epi and lab surveillance data into MESI surveillance platform, using unique identifiers for each case, which will be led and operationalized by the consultant. The consultant will continue to submit regular epidemiology reports to key stakeholders on a monthly basis; these reports will focus on pertussis and diphtheria epidemiology, to include case counts by age group, sex, department,</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="COVID-19 response activities have impacted ongoing vaccine-preventable disease work around the world, including Haiti. The coming year offers the opportunity to reset the agenda for current work in diphtheria and pertussis surveillance in Haiti. The objectives of this project will continue to be supporting the strengthening of diphtheria and pertussis surveillance, by reinforcing laboratory and data management capacities. Specifically, the project will support pertussis and diphtheria laboratory trainings and supplies; continued development of pertussis surveillance at sentinel sites and necessary staffing; assessment and dissemination of diphtheria epidemiology over the last 6 years; support of a consultant to strengthen routine analysis of surveillance data including risk assessement and preparation of regular epidemiology reports that will be shared with key stakeholders including Haiti Ministry of Health, CDC, PAHO; and, integration of pertussis and diphtheria surveillance data into an online surveillance platform which will allow linkage of epidemiology and laboratory data.">
      <location ref="HT"></location>
     </target>
     <actual value="Major Delays">
      <location ref="HT"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Meningitis surveillance continues in a minimum of 3 sites; PCR testing of 80% of meningitis specimens is completed by LNSP and reported back to hospitals within 7 days of receipt. Collect vaccine histories for &gt;50% of children age-eligible for PCV13. The consultant will submit regular epidemiology reports to key stakeholders on a monthly basis; these reports will focus on meningitis epidemiology, to include case counts by age group, sex, department, vaccination status, and laboratory confirmation status. The consultant will also provide feedback to departments on data missing from case reports and protection of protected health information.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Continue to provide epidemiological and laboratory assistance for vaccine-preventable meningitis surveillance; monitor the impact of the introduction of PCV13 on pneumococcal meningitis and the distribution of pneumococcal serotypes; monitor vaccination failures in children with pneumococcal meningitis.Support of a consultant to strengthen routine analysis of surveillance data including risk assessement and preparation of regular epidemiology reports that will be shared with key stakeholders including Haiti Ministry of Health, CDC, PAHO">
      <location ref="HT"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="HT"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Continue to provide epidemiological and laboratory assistance for vaccine-preventable meningitis surveillance; monitor the impact of the introduction of PCV13 on pneumococcal meningitis and the distribution of pneumococcal serotypes; monitor vaccination failures in children with pneumococcal meningitis.Support of a consultant to strengthen routine analysis of surveillance data including risk assessement and preparation of regular epidemiology reports that will be shared with key stakeholders including Haiti Ministry of Health, CDC, PAHO">
      <location ref="HT"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="HT"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Consistent reporting of meningitis cases and testing of CSF (and pleural fluids from pediatric pneumonia patients, where available) obtained from participating sentinel hospitals; 100% completion: produce and distribute quarterly meningitis surveillance reports for MOH and key partners; complete serotyping of all available pneumococcal+ specimens twice a year; 10% of specimens are shipped to CDC annually for QA/QC</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Continue to provide epidemiological and laboratory assistance for vaccine-preventable meningitis surveillance; monitor the impact of the introduction of PCV13 on pneumococcal meningitis and the distribution of pneumococcal serotypes; monitor vaccination failures in children with pneumococcal meningitis.Support of a consultant to strengthen routine analysis of surveillance data including risk assessement and preparation of regular epidemiology reports that will be shared with key stakeholders including Haiti Ministry of Health, CDC, PAHO">
      <location ref="HT"></location>
     </target>
     <actual value="On Track">
      <location ref="HT"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Health Financing/Sustainability</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Immunisation costing study carried out by MOH/EPI (country-led, with a capacity building component)</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Elaborer le plan de mise en oeuvre des activites des ann&#xE9;es 3,4 et 5 du RSS2 et le costing du PPAc (NIS) pour atteindre toutes les communaut&#xE9;s et pour plus d&apos;equite">
      <location ref="HT"></location>
     </target>
     <actual value="Major Delays">
      <location ref="HT"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Estimates of resource needs and resources available updated, comprehensive, and harmonised with other donors</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appui technique &#xE0; la gestion du projet RSS2">
      <location ref="HT"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="HT"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Elaborer le plan de mise en oeuvre des activites des ann&#xE9;es 3,4 et 5 du RSS2 et le costing du PPAc (NIS) pour atteindre toutes les communaut&#xE9;s et pour plus d&apos;equite">
      <location ref="HT"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="HT"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Elaborer le plan de mise en oeuvre des activites des ann&#xE9;es 3,4 et 5 du RSS2 et le costing du PPAc (NIS) pour atteindre toutes les communaut&#xE9;s et pour plus d&apos;equite">
      <location ref="HT"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="HT"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Capacity strengthening programme on immunisation costing/planning/budgeting developed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appui technique &#xE0; la gestion du projet RSS2">
      <location ref="HT"></location>
     </target>
     <actual value="On Track">
      <location ref="HT"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Data</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Immunisation registry (EIR, community registry etc) rolled out</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appui technique au MSPP dans la conduite de l&apos;utilisation pilote du registre nominal de vaccination informatis&#xE9; pour initier l&apos;utilisation de technologie num&#xE9;riques dans la collecte, anlayse et suivi des donn&#xE9;es de vaccination">
      <location ref="HT"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="HT"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appui technique au MSPP dans la conduite de l&apos;utilisation pilote du registre nominal de vaccination informatis&#xE9; pour initier l&apos;utilisation de technologie num&#xE9;riques dans la collecte, anlayse et suivi des donn&#xE9;es de vaccination">
      <location ref="HT"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="HT"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appui technique au MSPP dans la conduite de l&apos;utilisation pilote du registre nominal de vaccination informatis&#xE9; pour initier l&apos;utilisation de technologie num&#xE9;riques dans la collecte, anlayse et suivi des donn&#xE9;es de vaccination">
      <location ref="HT"></location>
     </target>
     <actual value="On Track">
      <location ref="HT"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Data desk review or triangulation analysis performed (coverage, surveillance, operational, others)</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appui technique aux departements sanitaires du Sud et de l&apos;Ouest dans la gestion des donn&#xE9;es de vaccination pour mieux identifier, suivre les progr&#xE8;s au niveau des communaut&#xE9;s manqu&#xE9;es et les z&#xE9;ro doses">
      <location ref="HT"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="HT"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appui technique &#xE0; l&apos;amelioration de la gestion des donnes de vaccination pour mieux atteindre les zeros doses et les communaut&#xE9;s manqu&#xE9;es">
      <location ref="HT"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="HT"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appui technique aux departements sanitaires du Sud et de l&apos;Ouest dans la gestion des donn&#xE9;es de vaccination pour mieux identifier, suivre les progr&#xE8;s au niveau des communaut&#xE9;s manqu&#xE9;es et les z&#xE9;ro doses">
      <location ref="HT"></location>
     </target>
     <actual value="On Track">
      <location ref="HT"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Routine immunisation coverage survey (national /targeted - various methods) implemented</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appui technique &#xE0; l&apos;amelioration de la gestion des donnes de vaccination pour mieux atteindre les zeros doses et les communaut&#xE9;s manqu&#xE9;es">
      <location ref="HT"></location>
     </target>
     <actual value="On Track">
      <location ref="HT"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">In-depth assessement of data quality (DQR, DQA, audit) performed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appui &#xE0; l&apos;analyse holistique de la qualit&#xE9; des donn&#xE9;es de vaccination pour une meilleure utilisation pour action afin d&apos;identifier les forces, faiblesses, menaces et opportunit&#xE9;s dans l&apos;idetification et l&apos;atteinte des zero doses et communaut&#xE9;s manquees">
      <location ref="HT"></location>
     </target>
     <actual value="Major Delays">
      <location ref="HT"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appui &#xE0; l&apos;analyse holistique de la qualit&#xE9; des donn&#xE9;es de vaccination pour une meilleure utilisation pour action afin d&apos;identifier les forces, faiblesses, menaces et opportunit&#xE9;s dans l&apos;idetification et l&apos;atteinte des zero doses et communaut&#xE9;s manquees">
      <location ref="HT"></location>
     </target>
     <actual value="Re-programmed">
      <location ref="HT"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">World Bank : Health Financing/Sustainability</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Atelier de restitution des r&#xE9;sultats pr&#xE9;liminaires de la mise en oeuvre du plan d&apos;action d&apos;am&#xE9;liorartion de la Gestion des Finances Publiques est realis&#xE9; avec le Gouvernement et les partenaires</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1) Une assistance technique sera fournie au gouvernement pour lui permettre de mettre en place des proc&#xE9;dures de planification, de r&#xE9;glementation, de passation des march&#xE9;s et de paiement appropri&#xE9;es lui permettant d&apos;acheter des vaccins sur son propre budget national 2020-2021, par l&apos;interm&#xE9;diaire du Fonds Rotatoire de l&apos;OPS. Cela impliquera une assistance technique et un dialogue avec les minist&#xE8;res des finances et de la sant&#xE9;, ainsi qu&apos;avec d&apos;autres entit&#xE9;s gouvernementales, le cas echeant. 2) La mise en oeuvre d&apos;activit&#xE9;s cl&#xE9;s d&#xE9;coulant du diagnostic de gestion des finances publiques dans le secteur de la sant&#xE9; (pr&#xE9;vu pour mi-2020) au niveau d&#xE9;partemental (institutions sanitaires, directions d&#xE9;partementales sanitaires et CDAI) afin d&apos;ameliorer l&apos;utilisation efficace et transparente des ressources, entre autres, pour les activit&#xE9;s de vaccination. Cette activite sera mise en oeuvre en coordination etroite avec les bailleurs actifs sur ce sujet.">
      <location ref="HT"></location>
     </target>
     <actual value="Major Delays">
      <location ref="HT"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1) Une assistance technique sera fournie au gouvernement pour lui permettre de mettre en place des proc&#xE9;dures de planification, de r&#xE9;glementation, de passation des march&#xE9;s et de paiement appropri&#xE9;es lui permettant d&apos;acheter des vaccins sur son propre budget national 2020-2021, par l&apos;interm&#xE9;diaire du Fonds Rotatoire de l&apos;OPS. Cela impliquera une assistance technique et un dialogue avec les minist&#xE8;res des finances et de la sant&#xE9;, ainsi qu&apos;avec d&apos;autres entit&#xE9;s gouvernementales, le cas echeant. 
2) La mise en oeuvre d&apos;activit&#xE9;s cl&#xE9;s d&#xE9;coulant du diagnostic de gestion des finances publiques dans le secteur de la sant&#xE9; (pr&#xE9;vu pour mi-2020) au niveau d&#xE9;partemental (institutions sanitaires, directions d&#xE9;partementales sanitaires et CDAI) afin d&apos;ameliorer l&apos;utilisation efficace et transparente des ressources, entre autres, pour les activit&#xE9;s de vaccination. Cette activite sera mise en oeuvre en coordination etroite avec les bailleurs actifs sur ce sujet.">
      <location ref="HT"></location>
     </target>
     <actual value="Major Delays">
      <location ref="HT"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1) Une assistance technique sera fournie au gouvernement pour lui permettre de mettre en place des proc&#xE9;dures de planification, de r&#xE9;glementation, de passation des march&#xE9;s et de paiement appropri&#xE9;es lui permettant d&apos;acheter des vaccins sur son propre budget national 2020-2021, par l&apos;interm&#xE9;diaire du Fonds Rotatoire de l&apos;OPS. Cela impliquera une assistance technique et un dialogue avec les minist&#xE8;res des finances et de la sant&#xE9;, ainsi qu&apos;avec d&apos;autres entit&#xE9;s gouvernementales, le cas echeant. 
2) La mise en oeuvre d&apos;activit&#xE9;s cl&#xE9;s d&#xE9;coulant du diagnostic de gestion des finances publiques dans le secteur de la sant&#xE9; (pr&#xE9;vu pour mi-2020) au niveau d&#xE9;partemental (institutions sanitaires, directions d&#xE9;partementales sanitaires et CDAI) afin d&apos;ameliorer l&apos;utilisation efficace et transparente des ressources, entre autres, pour les activit&#xE9;s de vaccination. Cette activite sera mise en oeuvre en coordination etroite avec les bailleurs actifs sur ce sujet.">
      <location ref="HT"></location>
     </target>
     <actual value="Major Delays">
      <location ref="HT"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Rapport Final dissimin&#xE9;</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1) Une assistance technique sera fournie au gouvernement pour lui permettre de mettre en place des proc&#xE9;dures de planification, de r&#xE9;glementation, de passation des march&#xE9;s et de paiement appropri&#xE9;es lui permettant d&apos;acheter des vaccins sur son propre budget national 2019-2020, par l&apos;interm&#xE9;diaire du Fonds Rotatoire de l&apos;OPS. Cela impliquera une assistance technique et un dialogue avec les minist&#xE8;res des finances et de la sant&#xE9;, ainsi qu&apos;avec d&apos;autres entit&#xE9;s gouvernementales, le cas echeant. Le cofinancement gouvernemental et l&apos;achat de vaccins par le biais de fonds nationaux ont &#xE9;t&#xE9; effectu&#xE9;s au cours de l&apos;exercice budg&#xE9;taire 2017-2018 pour la premi&#xE8;re fois depuis de nombreuse ann&#xE9;es, avec l&apos;aide de l&apos;assistance technique de la Banque mondiale financ&#xE9;e par le financement actuel de GAVI fourni &#xE0; la Banque. 2) la r&#xE9;alisation d?un diagnostic de la gestion des finances publiques dans le secteur de la sant&#xE9; afin d&apos;identifier les goulots d&apos;&#xE9;tranglement et les probl&#xE8;mes li&#xE9;s aux fonctions de planification, de budg&#xE9;tisation, d&apos;ex&#xE9;cution et de rapportage au niveau d&#xE9;partemental (Directions d&#xE9;partementales sanitaires) et au niveau central (Direction d&apos;administration et du Budget-DAB et Minist&#xE8;re de l&apos;&#xE9;conomie et des finances-MEF). Ce diagnostic incorporera une analyse approfondie de ces probl&#xE9;matiques pour la gestion des fonds li&#xE9;s &#xE0; la vaccination. Le rapport proposera des recommandations (qui seraient prioris&#xE9;es), y compris pour les aspects sp&#xE9;cifiques &#xE0; la gestion des ressources pour la vaccination afin d&apos;assurer une utilisation efficace et transparente de celles-ci.">
      <location ref="HT"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="HT"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Le MEF a recu la documentation complete du MSPP pour pouvoir realiser les paiements au Fonds Roratoire a partir des ressources gouvernementales du budget 2020-2021.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1) Une assistance technique sera fournie au gouvernement pour lui permettre de mettre en place des proc&#xE9;dures de planification, de r&#xE9;glementation, de passation des march&#xE9;s et de paiement appropri&#xE9;es lui permettant d&apos;acheter des vaccins sur son propre budget national 2020-2021, par l&apos;interm&#xE9;diaire du Fonds Rotatoire de l&apos;OPS. Cela impliquera une assistance technique et un dialogue avec les minist&#xE8;res des finances et de la sant&#xE9;, ainsi qu&apos;avec d&apos;autres entit&#xE9;s gouvernementales, le cas echeant. 2) La mise en oeuvre d&apos;activit&#xE9;s cl&#xE9;s d&#xE9;coulant du diagnostic de gestion des finances publiques dans le secteur de la sant&#xE9; (pr&#xE9;vu pour mi-2020) au niveau d&#xE9;partemental (institutions sanitaires, directions d&#xE9;partementales sanitaires et CDAI) afin d&apos;ameliorer l&apos;utilisation efficace et transparente des ressources, entre autres, pour les activit&#xE9;s de vaccination. Cette activite sera mise en oeuvre en coordination etroite avec les bailleurs actifs sur ce sujet.">
      <location ref="HT"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="HT"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Le MEF a recu la documentation complete du MSPP pour pouvoir realiser les paiements au Fonds Roratoire a partir des ressources gouvernementales du budget 2021-2022.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Une assistance technique sera fournie au gouvernement pour lui permettre de mettre en place des proc&#xE9;dures de planification, de r&#xE9;glementation, de passation des march&#xE9;s et de paiement appropri&#xE9;es lui permettant d&apos;acheter des vaccins sur son propre budget national 2021-2022, par l&apos;interm&#xE9;diaire du Fonds Rotatoire de l&apos;OPS. Cela impliquera une assistance technique et un dialogue avec les minist&#xE8;res des finances et de la sant&#xE9;, ainsi qu&apos;avec d&apos;autres entit&#xE9;s gouvernementales, le cas echeant.">
      <location ref="HT"></location>
     </target>
     <actual value="Completed">
      <location ref="HT"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Une assistance technique sera fournie au gouvernement pour lui permettre de mettre en place des proc&#xE9;dures de planification, de r&#xE9;glementation, de passation des march&#xE9;s et de paiement appropri&#xE9;es lui permettant d&apos;acheter des vaccins sur son propre budget national 2021-2022, par l&apos;interm&#xE9;diaire du Fonds Rotatoire de l&apos;OPS. Cela impliquera une assistance technique et un dialogue avec les minist&#xE8;res des finances et de la sant&#xE9;, ainsi qu&apos;avec d&apos;autres entit&#xE9;s gouvernementales, le cas echeant.">
      <location ref="HT"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="HT"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Une provision budgetaire est inclue dans le budget 2021-2022 pour le paiement au fnds rotatoire</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Une assistance technique sera fournie au gouvernement pour lui permettre de mettre en place des proc&#xE9;dures de planification, de r&#xE9;glementation, de passation des march&#xE9;s et de paiement appropri&#xE9;es lui permettant d&apos;acheter des vaccins sur son propre budget national 2021-2022, par l&apos;interm&#xE9;diaire du Fonds Rotatoire de l&apos;OPS. Cela impliquera une assistance technique et un dialogue avec les minist&#xE8;res des finances et de la sant&#xE9;, ainsi qu&apos;avec d&apos;autres entit&#xE9;s gouvernementales, le cas echeant.">
      <location ref="HT"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="HT"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">La collecte des donnees de l&apos;evaluation est effective sur le terrain</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Realiser une evaluation internationale du PEV">
      <location ref="HT"></location>
     </target>
     <actual value="Major Delays">
      <location ref="HT"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Les resultats de l&apos;evaluation internationale du PEV sont diffuses aupres des directions du MSPP et des partenaires techniques et financiers et les recommandations de l&apos;evaluation mises en oeuvre a tous les niveaux</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Realiser une evaluation internationale du PEV">
      <location ref="HT"></location>
     </target>
     <actual value="Major Delays">
      <location ref="HT"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">L&apos;evaluation a mi-parcours du PPAc 2016-2020 est realisee et diffusee;</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1) Appui a la coordination entre partenaires du programme, la mise en place du comit&#xE9; national ESAVI, 2) Appui aux activit&#xE9;s relatives au renforcement des capacit&#xE9;s manag&#xE9;riales et techniques &#xE0; tous les niveaux 3) Appui au d&#xE9;v. des plans op&#xE9;rationnels 201">
      <location ref="HT"></location>
     </target>
     <actual value="On Track">
      <location ref="HT"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Au moins 03 bulletins trimestriels ont ete produits et diffuses; un plan d&apos;amelioration de la qualite des donnees est disponible</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appui &#xE0; l&apos;utilisation des donn&#xE9;es dans le cadre des activit&#xE9;s de suivi et du suivi-&#xE9;valuation de la performance du PEV + soutien pour l&apos;&#xE9;laboration d&apos;un bulletin trimestriel et Reproduire et distribuer des outils de collecte de donn&#xE9;es">
      <location ref="HT"></location>
     </target>
     <actual value="On Track">
      <location ref="HT"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Health Information Systems (Data)</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1) 50% des activit&#xE9;s du plan d&apos;am&#xE9;lioration de la qualit&#xE9; des donn&#xE9;es sont mises en ?uvre dans les departements de l&apos;Ouest et du Sud;
2) Le JRF 2020 est &#xE9;labor&#xE9; et diffus&#xE9; &#xE0; temps;
3) Les r&#xE9;sultats des &#xE9;tudes sur les causes de taux d&apos;abandons &#xE9;lev&#xE9;s ou n&#xE9;gatifs ainsi que les raisons de faible couverture des vaccins aux premieres et deuxieme annee de vie sont disponibles et diffus&#xE9;s</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1) Appui &#xE0; l&apos;utilisation des donn&#xE9;es dans le cadre des activit&#xE9;s de suivi et du suivi-&#xE9;valuation de la performance du PEV
2) Appui &#xE0; la realisation d&apos;&#xE9;tudes sur les causes de taux d&apos;abandons &#xE9;lev&#xE9; ou n&#xE9;gatif ainsi que les raisons de faible couverture des vaccins a la 2e ann&#xE9;e de vie
3) Appui &#xE0; la r&#xE9;alisation de visites de supervision sp&#xE9;cifiques dans les DDS et les institutions sur la gestion des donn&#xE9;es du PEV
5) Appui &#xE0; la formation/recyclage des prestataires sur le syst&#xE8;me d&apos;information du PEV
6) appui &#xE0; l&apos;&#xE9;laboration d&apos;un bulletin mensuel du SIS">
      <location ref="HT"></location>
     </target>
     <actual value="Major Delays">
      <location ref="HT"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1) Appui &#xE0; l&apos;utilisation des donn&#xE9;es dans le cadre des activit&#xE9;s de suivi et du suivi-&#xE9;valuation de la performance du PEV
2) Appui &#xE0; la realisation d&apos;&#xE9;tudes sur les causes de taux d&apos;abandons &#xE9;lev&#xE9; ou n&#xE9;gatif ainsi que les raisons de faible couverture des vaccins a la 2e ann&#xE9;e de vie
3) Appui &#xE0; la r&#xE9;alisation de visites de supervision sp&#xE9;cifiques dans les DDS et les institutions sur la gestion des donn&#xE9;es du PEV
5) Appui &#xE0; la formation/recyclage des prestataires sur le syst&#xE8;me d&apos;information du PEV
6) appui &#xE0; l&apos;&#xE9;laboration d&apos;un bulletin mensuel du SIS">
      <location ref="HT"></location>
     </target>
     <actual value="Major Delays">
      <location ref="HT"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1) 50% des activit&#xE9;s du plan d&apos;am&#xE9;lioration de la qualit&#xE9; des donn&#xE9;es sont mises en ?uvre dans les departements de l&apos;Ouest et du Sud; 2) Le JRF 2020 est &#xE9;labor&#xE9; et diffus&#xE9; &#xE0; temps; 3) Les r&#xE9;sultats des &#xE9;tudes sur les causes de taux d&apos;abandons &#xE9;lev&#xE9;s ou n&#xE9;gatifs ainsi que les raisons de faible couverture des vaccins aux premieres et deuxieme annee de vie sont disponibles et diffus&#xE9;s</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1) Appui &#xE0; l&apos;utilisation des donn&#xE9;es dans le cadre des activit&#xE9;s de suivi et du suivi-&#xE9;valuation de la performance du PEV 2) Appui &#xE0; la realisation d&apos;&#xE9;tudes sur les causes de taux d&apos;abandons &#xE9;lev&#xE9; ou n&#xE9;gatif ainsi que les raisons de faible couverture des vaccins a la 2e ann&#xE9;e de vie 3) Appui &#xE0; la r&#xE9;alisation de visites de supervision sp&#xE9;cifiques dans les DDS et les institutions sur la gestion des donn&#xE9;es du PEV 5) Appui &#xE0; la formation/recyclage des prestataires sur le syst&#xE8;me d&apos;information du PEV 6) appui &#xE0; l&apos;&#xE9;laboration d&apos;un bulletin mensuel du SIS">
      <location ref="HT"></location>
     </target>
     <actual value="On Track">
      <location ref="HT"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1) Le rapport de formation de 100% des cadres du MSPP des departements de l&apos;Ouest et du Sud sur le SIS PEV est disponible ; 2) Au moins une session de monitoring des donn&#xE9;es est tenue dans les 10 d&#xE9;partements; 3) Le plan d&apos;am&#xE9;lioration de la qualit&#xE9; issue de l&apos;&#xE9;valuation internationale du PEV est diffus&#xE9; ; 4) 20% des recommandations du plan d&apos;amelioration de la qualite des donnees est&#xA0; est mis en ?uvre&#xA0; dans les departements prioritaires&#xA0; 5) Au moins 3 bulletins mensuels de suivi des donnees sont produits et diffuses;</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1) Appui &#xE0; l&apos;utilisation des donn&#xE9;es dans le cadre des activit&#xE9;s de suivi et du suivi-&#xE9;valuation de la performance du PEV 2) Appui &#xE0; la realisation d&apos;&#xE9;tudes sur les causes de taux d&apos;abandons &#xE9;lev&#xE9; ou n&#xE9;gatif ainsi que les raisons de faible couverture des vaccins a la 2e ann&#xE9;e de vie 3) Appui &#xE0; la r&#xE9;alisation de visites de supervision sp&#xE9;cifiques dans les DDS et les institutions sur la gestion des donn&#xE9;es du PEV 5) Appui &#xE0; la formation/recyclage des prestataires sur le syst&#xE8;me d&apos;information du PEV 6) appui &#xE0; l&apos;&#xE9;laboration d&apos;un bulletin mensuel du SIS">
      <location ref="HT"></location>
     </target>
     <actual value="On Track">
      <location ref="HT"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Programme Management - General</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1) Une conf&#xE9;rence scientifique sur le HPV est organis&#xE9;e 2) Une conference scientifique sur l&apos;analyse de l&apos;introduction de la vaccination contre l&apos;h&#xE9;patite B &#xE0; la naissance est conduite en collaboration avec le GTCV 3) Le PPAc 2021-2026 et le plan de viabilit&#xE9; du PEV sont valid&#xE9;s par le CCIA</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1) Appui &#xE0; la coordination entre partenaires du programme 2) Appui &#xE0; l&apos;&#xE9;laboration du PPAc 2021-2025 3) Appui au d&#xE9;veloppement des plans op&#xE9;rationnels 2020 4) Appui technique &#xE0; la mise en ?uvre et &#xE0; la coordination du projet de subvention (PEF TCA) 5) Appui &#xE0; l&apos;&#xE9;valuation finale du PPAc&#xA0; 2016-2020 6) Appui &#xE0; l&apos;&#xE9;laboration et mise en ?uvre d&apos;un exercice de simulation de r&#xE9;ponse &#xE0; une &#xE9;ventuelle &#xE9;pid&#xE9;mie de polio et/ou rougeole&#xA0; (1 exercice par maladie) 7) Appui &#xE0; l&apos;&#xE9;laboration de documents strat&#xE9;giques de l&apos;UCNPV 8) Appui &#xE0; l&apos;organisation de conf&#xE9;rences scientifiques sur les vaccins contre le HPV et l&apos;h&#xE9;patite B">
      <location ref="HT"></location>
     </target>
     <actual value="Major Delays">
      <location ref="HT"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1) Une conf&#xE9;rence scientifique sur le HPV est organis&#xE9;e
2) Une conference scientifique sur l&apos;analyse de l&apos;introduction de la vaccination contre l&apos;h&#xE9;patite B &#xE0; la naissance est conduite en collaboration avec le GTCV
3) Le PPAc 2021-2026 et le plan de viabilit&#xE9; du PEV sont valid&#xE9;s par le CCIA</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1) Appui &#xE0; la coordination entre partenaires du programme
2) Appui &#xE0; l&apos;&#xE9;laboration du PPAc 2021-2025
3) Appui au d&#xE9;veloppement des plans op&#xE9;rationnels 2020
4) Appui technique &#xE0; la mise en ?uvre et &#xE0; la coordination du projet de subvention (PEF TCA)
5) Appui &#xE0; l&apos;&#xE9;valuation finale du PPAc&#xA0; 2016-2020
6) Appui &#xE0; l&apos;&#xE9;laboration et mise en ?uvre d&apos;un exercice de simulation de r&#xE9;ponse &#xE0; une &#xE9;ventuelle &#xE9;pid&#xE9;mie de polio et/ou rougeole&#xA0; (1 exercice par maladie)
7) Appui &#xE0; l&apos;&#xE9;laboration de documents strat&#xE9;giques de l&apos;UCNPV
8) Appui &#xE0; l&apos;organisation de conf&#xE9;rences scientifiques sur les vaccins contre le HPV et l&apos;h&#xE9;patite B">
      <location ref="HT"></location>
     </target>
     <actual value="Major Delays">
      <location ref="HT"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1) Appui &#xE0; la coordination entre partenaires du programme
2) Appui &#xE0; l&apos;&#xE9;laboration du PPAc 2021-2025
3) Appui au d&#xE9;veloppement des plans op&#xE9;rationnels 2020
4) Appui technique &#xE0; la mise en ?uvre et &#xE0; la coordination du projet de subvention (PEF TCA)
5) Appui &#xE0; l&apos;&#xE9;valuation finale du PPAc&#xA0; 2016-2020
6) Appui &#xE0; l&apos;&#xE9;laboration et mise en ?uvre d&apos;un exercice de simulation de r&#xE9;ponse &#xE0; une &#xE9;ventuelle &#xE9;pid&#xE9;mie de polio et/ou rougeole&#xA0; (1 exercice par maladie)
7) Appui &#xE0; l&apos;&#xE9;laboration de documents strat&#xE9;giques de l&apos;UCNPV
8) Appui &#xE0; l&apos;organisation de conf&#xE9;rences scientifiques sur les vaccins contre le HPV et l&apos;h&#xE9;patite B">
      <location ref="HT"></location>
     </target>
     <actual value="Major Delays">
      <location ref="HT"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1) L&apos;&#xE9;valuation finale du PPAc 2016-2020 est finalise 2) Le PPAc 2021-2025 est &#xE9;labor&#xE9; 3) Le rapport final de l&apos;&#xE9;valuation internationale du PEV est &#xE9;labor&#xE9; et diffus&#xE9; 4) Le rapport annuel polio 2019 est &#xE9;labor&#xE9;</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1) Appui &#xE0; la coordination entre partenaires du programme 2) Appui &#xE0; l&apos;&#xE9;laboration du PPAc 2021-2025 3) Appui au d&#xE9;veloppement des plans op&#xE9;rationnels 2020 4) Appui technique &#xE0; la mise en ?uvre et &#xE0; la coordination du projet de subvention (PEF TCA) 5) Appui &#xE0; l&apos;&#xE9;valuation finale du PPAc&#xA0; 2016-2020 6) Appui &#xE0; l&apos;&#xE9;laboration et mise en ?uvre d&apos;un exercice de simulation de r&#xE9;ponse &#xE0; une &#xE9;ventuelle &#xE9;pid&#xE9;mie de polio et/ou rougeole&#xA0; (1 exercice par maladie) 7) Appui &#xE0; l&apos;&#xE9;laboration de documents strat&#xE9;giques de l&apos;UCNPV 8) Appui &#xE0; l&apos;organisation de conf&#xE9;rences scientifiques sur les vaccins contre le HPV et l&apos;h&#xE9;patite B">
      <location ref="HT"></location>
     </target>
     <actual value="On Track">
      <location ref="HT"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF : Demand Promotion &amp; ACSM</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">- 100 % des prestataires et les plateformes de la Soci&#xE9;t&#xE9; civile selectionn&#xE9;es sont form&#xE9;s en CIP et fonctionnels.


Un rapport de mise en oeuvre du Plan de communication mettant en exergue les goulots et defis , les realisations, bonnes pratiques et leco</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appui a la mise en oeuvre du Plan de Communication : 

-R&#xE9;viser les termes de r&#xE9;f&#xE9;rences pour le fonctionnement du sous-comit&#xE9; Communication &amp; mobilisation sociale pour le PEV et assurer son secr&#xE9;tariat.
-D&#xE9;velopper des mat&#xE9;riels &#xE9;ducatifs et promotionnels adapt&#xE9;s aux strat&#xE9;gies de Communication /Mobilisation sociale
-D&#xE9;velopper des plans types de Communication /Mobilisation sociale au niveau institutionnel et communautaire 
-Elaborer les outils pour le suivi et la supervision des activit&#xE9;s de Communication /Mobilisation sociale au niveau d&#xE9;partemental
-Appuyer les d&#xE9;partements sanitaires dans l?&#xE9;laboration de plans op&#xE9;rationnels de Communication /Mobilisation sociale
- Appuyer le d&#xE9;veloppement des formations en Communication /Mobilisation sociale
- Realiser la formation des prestataires sur la CIP
- Appuyer l&apos;elaboration d&apos;un bulletin trimestriel du Programme">
      <location ref="HT"></location>
     </target>
     <actual value="On Track">
      <location ref="HT"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">- 100 % des prestataires et les plateformes de la Soci&#xE9;t&#xE9; civile selectionn&#xE9;es sont form&#xE9;s en CIP et fonctionnels.


Un rapport de mise en oeuvre du Plan de communication mettant en exergue les goulots et defis , les realisations, bonnes pratiques et lecons apprises est disponible</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appui a la mise en oeuvre du Plan de Communication : 

-R&#xE9;viser les termes de r&#xE9;f&#xE9;rences pour le fonctionnement du sous-comit&#xE9; Communication &amp; mobilisation sociale pour le PEV et assurer son secr&#xE9;tariat.
-D&#xE9;velopper des mat&#xE9;riels &#xE9;ducatifs et promotionnels adapt&#xE9;s aux strat&#xE9;gies de Communication /Mobilisation sociale
-D&#xE9;velopper des plans types de Communication /Mobilisation sociale au niveau institutionnel et communautaire 
-Elaborer les outils pour le suivi et la supervision des activit&#xE9;s de Communication /Mobilisation sociale au niveau d&#xE9;partemental
-Appuyer les d&#xE9;partements sanitaires dans l?&#xE9;laboration de plans op&#xE9;rationnels de Communication /Mobilisation sociale
- Appuyer le d&#xE9;veloppement des formations en Communication /Mobilisation sociale
- Realiser la formation des prestataires sur la CIP
- Appuyer l&apos;elaboration d&apos;un bulletin trimestriel du Programme">
      <location ref="HT"></location>
     </target>
     <actual value="On Track">
      <location ref="HT"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">C4I strategy developed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appui a la mise en oeuvre du Plan de Communication :

D&#xE9;velopper des plans types de Communication /Mobilisation sociale au niveau institutionnel et communautaire
-Elaborer les outils pour le suivi et la supervision des activit&#xE9;s de Communication /Mobilisation sociale au niveau d&#xE9;partemental
-Appuyer les d&#xE9;partements sanitaires dans l?&#xE9;laboration de plans op&#xE9;rationnels de Communication /Mobilisation sociale
- Appuyer le d&#xE9;veloppement des formations en Communication /Mobilisation sociale
- Appuyer la r&#xE9;alisation de la formation des prestataires sur la CIP.

-Appuyer la preparation et la publication d&apos;un bulletin p&#xE9;riodique ( trimestriel ) pour le programme de vaccination.">
      <location ref="HT"></location>
     </target>
     <actual value="On Track">
      <location ref="HT"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF : Supply chain</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">% of target sites (provinces/districts) that have updated CCE management documents like CCE inventory, Operational Deployment Plan (ODP) or Cold Chain Expansion and Rehabilitation Plan, CCE maintenance strategy etc.)</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appui au renforcement de la Chaine du Froid et la Gestion Efficace des Vaccins :

-Appuyer l? &#xE9;laboration et la mise en ?uvre d&apos;un plan de maintenance des &#xE9;quipements Chaine du froid
- Appuyer la mise en place de bases de donn&#xE9;es en appui &#xE0; la gestion des vaccins et intrants au niveau des DDS.
-Appuyer la mise en ?uvre des recommandations du Plan d? am&#xE9;lioration de la GEV
- Appui a la r&#xE9;vision / reproduction et diss&#xE9;mination des proc&#xE9;dures (PONs)-Appuyer le fonctionnement du groupe de travail technique (NLWG) sur la logistique du PEV">
      <location ref="HT"></location>
     </target>
     <actual value="On Track">
      <location ref="HT"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF : Supply Chain &amp; Procurement</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">347/347 equipements acquis dans le cadre du CCEOP 3&amp; 4 sont installes</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appui au renforcement de la Chaine du Froid et la Gestion Efficace des Vaccins :

-Installer 323 refrigerateurs solaires; 24 congelateurs solaires; 21 Congelateurs electriques dans les Institutions de sante et les depots departementaux dans le cadre du CCEOP 3&amp;4.

-Appuyer l&apos;elaboration et la mise en oeuvre d&apos;un plan de maintenance des equipements Chaine du froid

-Suivi des recommandations du Plan d&apos;amelioration de la GEV
- Appui a l&apos;elaboration/revision des normes et procedures
- Appui au renforcement des capacites des 

-Appuyer le fonctionnement du groupe de travail technique (NLWG) sur la logistique du PEV">
      <location ref="HT"></location>
     </target>
     <actual value="On Track">
      <location ref="HT"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appui au renforcement de la Chaine du Froid et la Gestion Efficace des Vaccins :

-Installer 323 refrigerateurs solaires; 24 congelateurs solaires; 21 Congelateurs electriques dans les Institutions de sante et les depots departementaux dans le cadre du CCEOP 3&amp;4.

-Appuyer l&apos;elaboration et la mise en oeuvre d&apos;un plan de maintenance des equipements Chaine du froid

-Suivi des recommandations du Plan d&apos;amelioration de la GEV
- Appui a l&apos;elaboration/revision des normes et procedures
- Appui au renforcement des capacites des 

-Appuyer le fonctionnement du groupe de travail technique (NLWG) sur la logistique du PEV">
      <location ref="HT"></location>
     </target>
     <actual value="On Track">
      <location ref="HT"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Leadership, management, and coordination (LMC)</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Funds are available subnationally to execute planned activities</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appui technique au developpement de strategies nationales pour atteindre les zero doses et les communaut&#xE9;s manqu&#xE9;es">
      <location ref="HT"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="HT"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Annual workplan and budgets include interventions to reach zero dose children</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appui technique au developpement de strategies nationales pour atteindre les zero doses et les communaut&#xE9;s manqu&#xE9;es">
      <location ref="HT"></location>
     </target>
     <actual value="On Track">
      <location ref="HT"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Human Resources for Health</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Information on availability of vaccinators in priority areas (where missed communities and large numbers of zero dose children live) is integrated into national HIS and available for EPI national and sub-national managers and planners</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appui au suivi des tendances , monitoring et archivage au niveau de l&apos;UCNPV">
      <location ref="HT"></location>
     </target>
     <actual value="On Track">
      <location ref="HT"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Vaccinators and other PHC health workers are deployed to priority areas</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appui au suivi des tendances , monitoring et archivage au niveau de l&apos;UCNPV">
      <location ref="HT"></location>
     </target>
     <actual value="On Track">
      <location ref="HT"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Learning package for in-service training and performance management including supervision developed and tested</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appui technique &#xE0; l&apos;identification de strategies de prestations de services adapt&#xE9;s pour rattraper les enfants zero doses et manqu&#xE9;s ( microplanification; formation, supervision ...) au niveau de chaque communaut&#xE9;">
      <location ref="HT"></location>
     </target>
     <actual value="On Track">
      <location ref="HT"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Pre-service curricula with comprehensive and updated content on key aspects of vaccination and immunisation</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appui technique &#xE0; l&apos;identification de strategies de prestations de services adapt&#xE9;s pour rattraper les enfants zero doses et manqu&#xE9;s ( microplanification; formation, supervision ...) au niveau de chaque communaut&#xE9;">
      <location ref="HT"></location>
     </target>
     <actual value="On Track">
      <location ref="HT"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">System for regular monitoring and supervision of vaccinators / FHWs in priority areas is in place, allowing for assessing trend in performance</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appui technique &#xE0; quatre departements sanitaires dans la mise en oeuvre de strategies innovantes efficaces ( approvisionnement en vaccins; supervision; gestion des donn&#xE9;es....) pour atteindre les zero doses">
      <location ref="HT"></location>
     </target>
     <actual value="On Track">
      <location ref="HT"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appui technique &#xE0; quatre departements sanitaires dans la mise en oeuvre de strategies innovantes efficaces ( approvisionnement en vaccins; supervision; gestion des donn&#xE9;es....) pour atteindre les zero doses">
      <location ref="HT"></location>
     </target>
     <actual value="On Track">
      <location ref="HT"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF : Financial/General Management</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Accounting/financial management system design document submitted</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer le MSPP dans le renforcement du programme notamment :
- Appuyer le renforcement de la gestion financiere ( superv., rencontre periodique etc..)
Planification et mise en ?uvre du Plan Op&#xE9;rationnel Annuel int&#xE9;gr&#xE9;
- Appui a l&apos;organisation des r&#xE9;unions trimestrielles de suivi du programme
- Appui a l&apos;organisation des r&#xE9;unions mensuelles du Comite technique du programme ;
 Appui a la conduite des Evaluations conjointes annuelles
- Suivi des activit&#xE9;s des groupes techniques C4D/Mobilisation sociale, Logistique/CDF &amp; Suivi/ Evaluation
-Appui a la pr&#xE9;paration, la riposte et a l? &#xE9;valuation toutes situation d&apos;urgence li&#xE9;e au programme">
      <location ref="HT"></location>
     </target>
     <actual value="Completed">
      <location ref="HT"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">PFM/FM assessment/mapping/diagnostic/roadmap/financial reform/financial strategy report submitted timely and of satisfactory quality</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer le MSPP dans le renforcement du programme notamment :
- Appuyer le renforcement de la gestion financiere ( superv., rencontre periodique etc..)
Planification et mise en ?uvre du Plan Op&#xE9;rationnel Annuel int&#xE9;gr&#xE9;
- Appui a l&apos;organisation des r&#xE9;unions trimestrielles de suivi du programme
- Appui a l&apos;organisation des r&#xE9;unions mensuelles du Comite technique du programme ;
 Appui a la conduite des Evaluations conjointes annuelles
- Suivi des activit&#xE9;s des groupes techniques C4D/Mobilisation sociale, Logistique/CDF &amp; Suivi/ Evaluation
-Appui a la pr&#xE9;paration, la riposte et a l? &#xE9;valuation toutes situation d&apos;urgence li&#xE9;e au programme">
      <location ref="HT"></location>
     </target>
     <actual value="On Track">
      <location ref="HT"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">CDC Foundation</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Diphtheria: case-based national diphtheria surveillance continues; discrepancies between periperhal and national level diphtheria data assessed and resolved; unique identifiers present on 100% of suspected cases. Pertussis: surveillancce continues at 4 sentinel sites; specimens successfully collected, transported and tested at national reference lab for &gt;80% of suspect cases; results feedback from national lab to sentinel sites within 7 days of specimen receipt at national lab for &gt;80% of suspect cases; generation of monthly pertussis feedback summaries for participating sentinel hospitals; continued periodic refresher training of pertussis surveillance at sentinel hospitals as needed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Haiti continues to experience an elevated number of diphtheria cases and burden of pertussis disease is unclear. Therefore activitites will continue to focus on strengthening diphtheria surveillance, through reinforcement of laboratory confirmation, and assessing burden of illness at both peripheral and national levels. Efforts to strengthen pertussis surveillance will include supporting sentinel site laboratory-based surveillance in the metropolitan Port-au-Prince area, in order to better understand pertussis disease burden.">
      <location ref="HT"></location>
     </target>
     <actual value="Completed">
      <location ref="HT"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Meningitis surveillance continues in 3 sites; improved turn around of PCR testing of meningitis specimens by LNSP. Collect vaccine histories for &gt;80% of children age-eligible for PCV14. Compare serotype distribution pre-post PCV13 introduction</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Strengthen and continue meningitis surveillance, monitoring impact of PCV13 on pneumococcal meningitis and pneumococcal serotype distribution. Monitor for vaccine failures among children with pneumococcal meningitis.">
      <location ref="HT"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="HT"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Meningitis surveillance continues in a minimum of 3 sites; PCR testing of 80% of meningitis specimens is completed by LNSP and reported back to hospitals within 7 days of receipt. Collect vaccine histories for &gt;70% of children age-eligible for PCV13</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Continuer &#xE0; fournir une assistance &#xE9;pid&#xE9;miologique et de laboratoire pour la surveillance de la m&#xE9;ningite &#xE0; pr&#xE9;vention vaccinale; surveiller l&apos;impact de l&apos;introduction du PCV13 sur les m&#xE9;ningites &#xE0; pneumocoques et la distribution des s&#xE9;rotypes de pneumocoques; surveiller les &#xE9;checs de vaccination chez les enfants atteints de m&#xE9;ningite &#xE0; pneumocoque.">
      <location ref="HT"></location>
     </target>
     <actual value="On Track">
      <location ref="HT"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Diphtheria: case-based national diphtheria surveillance continues, along with ongoing assessment of discrepancies in surveillance data between national and peripheral level.Unique identifiers present on 100% of suspected cases.Pertussis: surveillance continues at a minimum of 4 sentinel sites in Port-au-Prince; specimens successfully collected, transported and tested by PCR at national reference lab for &gt;80% of suspect cases; results feedback from national lab to sentinel sites within 7 days of specimen receipt at national lab for &gt;80% of suspect cases; generation of monthly pertussis feedback summaries for participating sentinel hospitals; continued periodic refresher training of pertussis surveillance at sentinel hospitals as needed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Continuer &#xE0; soutenir le renforcement de la surveillance de la dipht&#xE9;rie et de la coqueluche en renfor&#xE7;ant les capacit&#xE9;s de laboratoire et la gestion des donn&#xE9;es.">
      <location ref="HT"></location>
     </target>
     <actual value="On Track">
      <location ref="HT"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Diphtheria: case-based national diphtheria surveillance continues; discrepancies between periperhal and national level diphtheria data assessed and resolved; plan for attaching unique identifiers to all suspected cases developed and introduced. Pertussis:</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Haiti continues to experience an elevated number of diphtheria cases and burden of pertussis disease is unclear. Therefore activitites will continue to focus on strengthening diphtheria surveillance, through reinforcement of laboratory confirmation, and a">
      <location ref="HT"></location>
     </target>
     <actual value="On Track">
      <location ref="HT"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Diphtheria: case-based national diphtheria surveillance continues; discrepancies between periperhal and national level diphtheria data assessed and resolved; unique identifiers present on &gt;80% of suspected cases. Pertussis: surveillancce increases to 4 se</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Haiti continues to experience an elevated number of diphtheria cases and burden of pertussis disease is unclear. Therefore activitites will continue to focus on strengthening diphtheria surveillance, through reinforcement of laboratory confirmation, and a">
      <location ref="HT"></location>
     </target>
     <actual value="On Track">
      <location ref="HT"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">CDC Foundation : Health Information Systems (Data)</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Diphtheria: case-based national diphtheria surveillance continues, along with ongoing assessment of discrepancies in surveillance data between national and peripheral level. Unique identifiers present on 100% of suspected cases. Training completed in poorly performing departments on improving surveillance data quality.Pertussis: surveillance continues at a minimum of 4 sentinel sites with expansion to additional sites if feasible; specimens successfully collected, transported and tested by PCR at national reference lab for &gt;90% of suspect cases; results feedback from national lab to sentinel sites within 7 days of specimen receipt at national lab for &gt;90% of suspect cases; generation of monthly pertussis feedback summaries for participating sentinel hospitals; continued periodic refresher training of pertussis surveillance at sentinel hospitals as needed. Review of yearly data and report generated for MOH and partners; areas for data management improvement noted.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Continuer &#xE0; soutenir le renforcement de la surveillance de la dipht&#xE9;rie et de la coqueluche en renfor&#xE7;ant les capacit&#xE9;s de laboratoire et la gestion des donn&#xE9;es.">
      <location ref="HT"></location>
     </target>
     <actual value="Major Delays">
      <location ref="HT"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Continuer &#xE0; soutenir le renforcement de la surveillance de la dipht&#xE9;rie et de la coqueluche en renfor&#xE7;ant les capacit&#xE9;s de laboratoire et la gestion des donn&#xE9;es.">
      <location ref="HT"></location>
     </target>
     <actual value="Major Delays">
      <location ref="HT"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Continuer &#xE0; soutenir le renforcement de la surveillance de la dipht&#xE9;rie et de la coqueluche en renfor&#xE7;ant les capacit&#xE9;s de laboratoire et la gestion des donn&#xE9;es.">
      <location ref="HT"></location>
     </target>
     <actual value="Major Delays">
      <location ref="HT"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Meningitis surveillance continues in a minimum of 3 sites; PCR testing of 80% of meningitis specimens is completed by LNSP and reported back to hospitals within 7 days of receipt. Vaccine histories are collected for &gt;70% of children age-eligible for PCV13.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Continuer &#xE0; fournir une assistance &#xE9;pid&#xE9;miologique et de laboratoire pour la surveillance de la m&#xE9;ningite &#xE0; pr&#xE9;vention vaccinale; surveiller l&apos;impact de l&apos;introduction du PCV13 sur les m&#xE9;ningites &#xE0; pneumocoques et la distribution des s&#xE9;rotypes de pneumocoques; surveiller les &#xE9;checs de vaccination chez les enfants atteints de m&#xE9;ningite &#xE0; pneumocoque.">
      <location ref="HT"></location>
     </target>
     <actual value="On Track">
      <location ref="HT"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Continuer &#xE0; fournir une assistance &#xE9;pid&#xE9;miologique et de laboratoire pour la surveillance de la m&#xE9;ningite &#xE0; pr&#xE9;vention vaccinale; surveiller l&apos;impact de l&apos;introduction du PCV13 sur les m&#xE9;ningites &#xE0; pneumocoques et la distribution des s&#xE9;rotypes de pneumocoques; surveiller les &#xE9;checs de vaccination chez les enfants atteints de m&#xE9;ningite &#xE0; pneumocoque.">
      <location ref="HT"></location>
     </target>
     <actual value="On Track">
      <location ref="HT"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Diphtheria: case-based national diphtheria surveillance continues. Expansion of diphtheria laboratory capacity to regional laboratories as feasible; regional laboratory training completed. Assessment of national surveillance data (completeness and ability to link lab and epi data) completed. Targeted feedback shared with departments with poor data completeness. A percentage of specimens tested by LNSP shipped to CDC annually for QA/QC.Pertussis: surveillance continues at a minimum of 4 sentinel sites. Generation of quarterly surveillance reports for MOH and partners. A percentage of specimens tested by LNSP shipped to CDC annually for QA/QC.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Continuer &#xE0; soutenir le renforcement de la surveillance de la dipht&#xE9;rie et de la coqueluche en renfor&#xE7;ant les capacit&#xE9;s de laboratoire et la gestion des donn&#xE9;es.">
      <location ref="HT"></location>
     </target>
     <actual value="On Track">
      <location ref="HT"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF : Service Delivery</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Service delivery related barriers of missed communities to access immunisation services identified and prioritized</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Encadrer la&#xA0;mise en ?uvre de la strat&#xE9;gie ACD &#xE0; base factuelle dans les 38 Communes ciblees des Departments de l&apos;Ouest et du Sud pour renforcer la couverture vaccinale, reduire la charge de morbidit&#xE9; et am&#xE9;liorer l&apos;&#xE9;quit&#xE9; avec emhase sur la recherche des enfants zero dose
- Planification et gestion des ressources
- Renforcement des liens avec le communaute
- Conduite des strategies avancees
- Realisation de supervision formative
- Monitoring pour action">
      <location ref="HT"></location>
     </target>
     <actual value="On Track">
      <location ref="HT"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF : Programme Implementation/Coverage &amp; Equity</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Un rapport de mise en oeuvre de l&apos;ACD disponible avec CV renforcee et charge de morbidite liee aux MEV reduite de facon equitable dans 38 Communes ciblees des 2 Departements (Sud &amp;Ouest) .</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Encadrer la&#xA0;mise en ?uvre de la strat&#xE9;gie ACD &#xE0; base factuelle dans les 38 Communes ciblees des Departments de l&apos;Ouest et du Sud pour renforcer la couverture vaccinale, reduire la charge de morbidit&#xE9; et am&#xE9;liorer l&apos;&#xE9;quit&#xE9; d&apos;ici Juin 2021 notamment : 
- Planification et gestion des ressources 
- Renforcement des liens avec le communaute 
- Conduite des strategies avancees (notamment la recherche active des zero doses) 
- Realisation de supervision formative 
- Monitoring pour action ( Monitorage en Temps Reel)">
      <location ref="HT"></location>
     </target>
     <actual value="On Track">
      <location ref="HT"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Encadrer la&#xA0;mise en ?uvre de la strat&#xE9;gie ACD &#xE0; base factuelle dans les 38 Communes ciblees des Departments de l&apos;Ouest et du Sud pour renforcer la couverture vaccinale, reduire la charge de morbidit&#xE9; et am&#xE9;liorer l&apos;&#xE9;quit&#xE9; d&apos;ici Juin 2021 notamment : 
- Planification et gestion des ressources 
- Renforcement des liens avec le communaute 
- Conduite des strategies avancees (notamment la recherche active des zero doses) 
- Realisation de supervision formative 
- Monitoring pour action ( Monitorage en Temps Reel)">
      <location ref="HT"></location>
     </target>
     <actual value="On Track">
      <location ref="HT"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Un document est d&#xE9;velopp&#xE9; avec le MSPP/PEV qui d&#xE9;taille les &quot;le&#xE7;ons apprises&quot; des visites de supervision.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Superviser le cadre de mise en ?uvre de la strat&#xE9;gie ACD &#xE0; base factuelle pour la couverture, le renforcement des capacit&#xE9;s, la r&#xE9;duction de la charge de morbidit&#xE9; et l&apos;am&#xE9;lioration de l&apos;&#xE9;quit&#xE9; lors des visites de terrain du personnel et du consultant">
      <location ref="HT"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="HT"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Les 38 communes selectionnees (RED) du sud et de l&apos;Ouest implementent l&apos;approche RED.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Suivi de la mise en ?uvre du plan de mobilisation sociale et de communication soulignant l&apos;approche RED avec l&apos;aide d&apos;un consultant de l&apos;UNICEF en organisant des ateliers. Renforcer l&apos;implication et l&apos;appropriation des communautes">
      <location ref="HT"></location>
     </target>
     <actual value="On Track">
      <location ref="HT"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Rapport sur les resultats de la mise en oeuvre de&#xA0;l&apos;approche RED est partarg&#xE9; et les lecons apprises sont document&#xE9;es.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Suivi de la mise en ?uvre du plan de mobilisation sociale et de communication soulignant l&apos;approche RED avec l&apos;aide d&apos;un consultant de l&apos;UNICEF en organisant des ateliers. Renforcer l&apos;implication et l&apos;appropriation des communautes">
      <location ref="HT"></location>
     </target>
     <actual value="On Track">
      <location ref="HT"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">University of Oslo : Data</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Covid-19 digital package installed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support planning, configuration and management of COVID-19 surveillance">
      <location ref="HT"></location>
     </target>
     <actual value="Completed">
      <location ref="HT"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1. EPI digital package installed
2. Data quality app installed
3. EPI legacy data migrated
4. Training given</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support transitioning to DHIS2 for EPI">
      <location ref="HT"></location>
     </target>
     <actual value="Re-programmed">
      <location ref="HT"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Core team trained on COVID-19 digital data package and know how to use it.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support planning, configuration and management of COVID-19 surveillance">
      <location ref="HT"></location>
     </target>
     <actual>
      <location ref="HT"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Transition plan for EPI in place with agreed date for end of parallel system
Costed scale up plan exist</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support transitioning to DHIS2 for EPI">
      <location ref="HT"></location>
     </target>
     <actual>
      <location ref="HT"></location>
     </actual>
    </period>
   </indicator>
  </result>
 </iati-activity>
</iati-activities>
